{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:58:46Z","timestamp":1770739126348,"version":"3.49.0"},"reference-count":43,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,11,28]]},"DOI":"10.1536\/ihj.20-321","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T22:07:12Z","timestamp":1605218832000},"page":"1236-1244","source":"Crossref","is-referenced-by-count":4,"title":["Sex Differences in Clinical Characteristics and 2-Year Prognosis of Patients with Heart Failure Grouped by Left Ventricular Ejection Fraction Status"],"prefix":"10.1536","volume":"61","author":[{"given":"Conglin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Tianjin Medical University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Tianjin Medical University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Tianjin Medical University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Tianjin Medical University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zimo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Tianjin Medical University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Tianjin Medical University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yancy CW, Jessup M, Bozkurt B, <i>et al<\/i>. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol 2017; 70: 776-803.","DOI":"10.1016\/j.jacc.2017.04.025"},{"key":"2","first-page":"e146","volume":"135","year":"2017","unstructured":"2. Benjamin EJ, Blaha MJ, Chiuve SE, <i>et al<\/i>. Heart disease and stroke Statistics-2017 update: A report from the American Heart Association. Circulation 2017; 135: e146-146e603.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"3","unstructured":"3. Expert Committee on rational drug use of national health and Family Planning Commission. Guidelines for rational use of drugs of heart failure. 2nd ed. 2019; 11: 1-78."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016; 18: 242-52.","DOI":"10.1002\/ejhf.483"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ponikowski P, Voors AA, Anker SD, <i>et al<\/i>. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Braunwald E. Heart failure. JACC Heart Fail 2013; 1: 1-20.","DOI":"10.1016\/j.jchf.2012.10.002"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Lloyd-Jones D, Adams R, Carnethon M, <i>et al<\/i>. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21-e181.","DOI":"10.1161\/CIRCULATIONAHA.108.191261"},{"key":"8","unstructured":"8. O&apos;Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 13: S107-12."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in The UK. Eur J Heart Fail 2002; 4: 361-71.","DOI":"10.1016\/S1388-9842(01)00198-2"},{"key":"10","unstructured":"10. Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure 2018. Zhonghua Xin Xue Guan Bing Za Zhi 2018; 46: 760-89."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rickenbacher P, Kaufmann BA, Maeder MT, <i>et al<\/i>. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with congestive heart failure (Time-CHF). Eur J Heart Fail 2017; 19: 1586-96.","DOI":"10.1002\/ejhf.798"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chioncel O, Lainscak M, Seferovic PM, <i>et al<\/i>. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2017; 19: 1574-85.","DOI":"10.1002\/ejhf.813"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Koh AS, Tay WT, Teng THK, <i>et al<\/i>. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail 2017; 19: 1624-34.","DOI":"10.1002\/ejhf.945"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Savarese G, Vedin O, D&apos;Amario D, <i>et al<\/i>. Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. JACC Heart Fail 2019; 7: 306-17.","DOI":"10.1016\/j.jchf.2018.11.019"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shah KS, Xu H, Matsouaka RA, <i>et al<\/i>. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol 2017; 70: 2476-86.","DOI":"10.1016\/j.jacc.2017.08.074"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lam CSP, Gamble GD, Ling LH, <i>et al<\/i>. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Eur Heart J 2018; 39: 1770-80.","DOI":"10.1093\/eurheartj\/ehy005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. G\u00f3mez-Otero I, Ferrero-Gregori A, Varela Rom\u00e1n A, <i>et al<\/i>. Mid-range ejection fraction does not permit risk stratification among patients hospitalized for heart failure. Rev Esp Cardiol Engl Ed 2017; 70: 338-46.","DOI":"10.1016\/j.recesp.2016.08.019"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fr\u00f6hlich H, Rosenfeld N, T\u00e4ger T, <i>et al<\/i>. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart 2019; 105: 1252-9.","DOI":"10.1136\/heartjnl-2018-314256"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Margolis G, Khoury S, Ben-Shoshan J, <i>et al<\/i>. Prognostic implications of mid-range left ventricular ejection fraction on patients presenting with ST-segment elevation myocardial infarction. Am J Cardiol 2017; 120: 186-90.","DOI":"10.1016\/j.amjcard.2017.04.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cleland JGF, Lyon AR, McDonagh T, McMurray JJV. The year in cardiology: heart failure. Eur Heart J 2020; 41: 1232-48.","DOI":"10.1093\/eurheartj\/ehz949"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Scrutinio D, Guida P, Passantino A, <i>et al<\/i>. Female gender and mortality risk in decompensated heart failure. Eur J Intern Med 2018; 51: 34-40.","DOI":"10.1016\/j.ejim.2018.01.011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zafrir B, Lund LH, Laroche C, <i>et al<\/i>. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J 2018; 39: 4277-84.","DOI":"10.1093\/eurheartj\/ehy626"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dewan P, R\u00f8rth R, Raparelli V, <i>et al<\/i>. Sex-related differences in heart failure with preserved ejection fraction. Circ Heart Fail 2019; 12: e006539.","DOI":"10.1161\/CIRCHEARTFAILURE.119.006539"},{"key":"24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/01.CIR.103.3.375","volume":"103","year":"2001","unstructured":"24. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency bisoprolol Study (CIBIS II). Circulation 2001; 103: 375-80.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yu Y, Gupta A, Wu C, <i>et al<\/i>. Characteristics, management, and outcomes of patients hospitalized for heart failure in China: the China PEACE retrospective heart failure study. J Am Heart Assoc 2019; 8: e012884.","DOI":"10.1161\/JAHA.119.012884"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Beale AL, Meyer P, Marwick TH, Lam CSP, Kaye DM. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation 2018; 138: 198-205.","DOI":"10.1161\/CIRCULATIONAHA.118.034271"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Keller KM, Howlett SE. Sex differences in the biology and pathology of the aging heart. Can J Cardiol 2016; 32: 1065-73.","DOI":"10.1016\/j.cjca.2016.03.017"},{"key":"28","unstructured":"28. <i>China Statistics Press. China Statistical Yearbook<\/i>. 2019."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006; 5: 425-38.","DOI":"10.1038\/nrd2032"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lam CSP, Arnott C, Beale AL, <i>et al<\/i>. Sex differences in heart failure. Eur Heart J 2019; 40: 3859c-68c.","DOI":"10.1093\/eurheartj\/ehz835"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Santema BT, Ouwerkerk W, Tromp J, <i>et al<\/i>. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study. Lancet 2019; 394: 1254-63.","DOI":"10.1016\/S0140-6736(19)31792-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Jochmann N, Stangl K, Garbe E, Baumann G, Stangl V. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 2005; 26: 1585-95.","DOI":"10.1093\/eurheartj\/ehi397"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lau ES, Cunningham T, Hardin KM, <i>et al<\/i>. Sex differences in cardiometabolic traits and determinants of exercise capacity in heart failure with preserved ejection fraction. JAMA Cardiol 2020; 5: 30-7.","DOI":"10.1001\/jamacardio.2019.4150"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Templin C, Ghadri JR, Napp LC. Takotsubo (stress) cardiomyopathy. N Engl J Med 2015; 373: 2689-91.","DOI":"10.1056\/NEJMoa1406761"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lam CS, Cheng S, Choong K, <i>et al<\/i>. Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol 2011; 58: 618-26.","DOI":"10.1016\/j.jacc.2011.03.042"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Levy D, Kenchaiah S, Larson MG, <i>et al<\/i>. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-402.","DOI":"10.1056\/NEJMoa020265"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Dewan P, R\u00f8rth R, Jhund PS, <i>et al<\/i>. Differential impact of heart failure with reduced ejection fraction on men and women. J Am Coll Cardiol 2019; 73: 29-40.","DOI":"10.1016\/j.jacc.2018.09.081"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Roger VL, Weston SA, Redfield MM, <i>et al<\/i>. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344-50.","DOI":"10.1001\/jama.292.3.344"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. O&apos;Meara E, Clayton T, McEntegart MB, <i>et al<\/i>. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the candesartan in Heart failure: assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2007; 115: 3111-20.","DOI":"10.1161\/CIRCULATIONAHA.106.673442"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Mart\u00ednez-Sell\u00e9s M, Doughty RN, Poppe K, <i>et al<\/i>. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail 2012; 14: 473-9.","DOI":"10.1093\/eurjhf\/hfs026"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Rusinaru D, Mahjoub H, Goissen T, Massy Z, Peltier M, Tribouilloy C. Clinical features and prognosis of heart failure in women. A 5-year prospective study. Int J Cardiol 2009; 133: 327-35.","DOI":"10.1016\/j.ijcard.2007.12.113"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Chung J, Kim HL, Kim MA, <i>et al<\/i>. Sex differences in long-term clinical outcomes in patients hospitalized for acute heart failure: A report from the Korean Heart Failure Registry. J Womens Health (Larchmt) 2019; 28: 1606-13.","DOI":"10.1089\/jwh.2018.7404"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Opasich C, Tavazzi L, Lucci D, <i>et al<\/i>. Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000; 86: 353-7.","DOI":"10.1016\/S0002-9149(00)00934-6"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/6\/61_20-321\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:46:15Z","timestamp":1606535175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/6\/61_20-321\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-321","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]}}}